SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 75.40+5.5%Nov 11 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (1764)4/5/2007 3:06:25 PM
From: Jibacoa  Read Replies (1) of 3722
 
NTMD seems to have found support at the $3 level.

In spite of 7% lower revenues on the 4thQ, it was able to trim ist losses for the 3rd consecutive Q.

The loss in 2006 was $1.61/shr vs. $3.49 in 2005 & the EL for 2007 is $0.90/shr with another 50% cut expected in 2008.

It has announced in the last few months a licensing agreement with ELN to develop an extended release version of Bidil.

The stock has closed its UG of Jan 24.

bigcharts.marketwatch.com

The stock trades below its $8 IPO price in Nov 20003 & it seems that the R/R isn't bad at present levels.Insiders reportedly hold around 40% & institutions 17% with the float around 10.4M

bigcharts.marketwatch.com

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext